Currently, another small molecule GLP-1R agonist called compound 29 (DA-302168S) has also shown good therapeutic potential (Dong et al., 2025)
Across this population, GLP-1 treatment was found to reduce the risk of blood clots by 17%, of pulmonary embolism by 31%, and of death by 44%
[22] IL-10 and Treg cells promote balance (homeostasis), and self-tolerance and help prevent autoimmunity and allergies
M.PalacioA.TamarizL.FlorezH
Metabolic abnormalities yield menstrual disorders and ovulatory infertility via perturbed feedback cycles, persistently elevated low-grade inflammation, and aberrant steroidogenesis
Managing this condition involves continuous glucose monitoring, personalized glucose targets, and healthcare support